Article
Assessment of binding affinity to 5-hydroxytryptamine 2A (5-HT2A) receptor and inverse agonist activity of naftidrofuryl: comparison with those of sarpogrelate.
Journal of pharmacological sciences - 1 Aug 2009
Aly Saida Abdel Regal, Hossain Murad, Bhuiyan Mohiuddin Ahmed, Nakamura Takashi, Nagatomo Takafumi
Abstract excerpt
Naftidrofuryl is a peripheral vasodilator that has been clinically used in the treatment of intermittent claudication and dementia. It has 5-hydroxytryptamine 2 (5-HT(2)) antiserotonergic activity and selectively binds with the 5-HT(2) receptor. The purpose of the present study is to assess the binding affinity and functional potency of naftidrofuryl to the 5-HT(2A) receptor, to find out the inverse agonist...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
